Concomitant VTE increased risks for mortality and hemorrhage in older patients with cancer, with risk varying by cancer type
- Concomitant VTE increased risks for mortality and hemorrhage in older patients with cancer, with risk varying by cancer type: COMMENTARY. Stevens, Scott M.; Elliott, C. Gregory // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p51
The authors' comment on the prognosis study that states that concomitant venous thromboembolism (VTE) increased risks for mortality and hemorrhage in older patients with cancer with risk varying by cancer type. They argue that although we know that the risk for both thrombosis and hemorrhage is...
- Prostate cancer mortality: U.S. vs. U.K. Adams, Stacey L.; Dickinson, Cara; Shafer, Emily // Hem/Onc Today;5/25/2008, Vol. 9 Issue 9, p31
The article discusses a study of prostate cancer mortality in the U.S. and Great Britain, which was published in "Lancet Oncology." It showed that age-specific and age-adjusted prostate cancer mortality peaked during the early 1990s. Age-adjusted mortality in the U.S. dropped 4.17% each year...
- Trends of population-based breast cancer survival in Germany and the US: Decreasing discrepancies, but persistent survival gap of elderly patients in Germany. Holleczek, Bernd; Brenner, Hermann // BMC Cancer;2012, Vol. 12 Issue 1, p317
Background: Studies have revealed both higher cancer survival in the US than in Germany and substantial improvement of cancer survival in the past in these countries. This population-based study aims at comparing most recent 5-year relative survival of breast cancer patients and preceding trends...
- Antibiotics double bleed risk in patients on warfarin. // Pulse;2/22/2012, Vol. 72 Issue 7, p10
The article reports that a U.S. study found older patients that use warfarin has double the risk of bleeding with concurrent use of antibiotics.
- Elderly missing out on warfarin therapy. // Pulse;11/7/2012, Vol. 72 Issue 36, p14
The article informs the ratio of elderly patients going for warfarin therapy is less as compared to the younger group despite the fact that their age puts them at higher risk of bleeding, as warned by the researchers in Great Britain.
- Age is a prognostic factor affecting survival in lung cancer patients. TAS, FARUK; CIFTCI, RUMEYSA; KILIC, LEYLA; KARABULUT, SENEM // Oncology Letters;2013, Vol. 6 Issue 5, p1507
Despite all efforts at management, prognosis of advanced lung cancer is extremely poor, with a median survival time of ~1 year. The number of cancer patients aged >70 years is significantly increased among the cancer patient population. The aim of this study was to investigate the clinical...
- VTE increased mortality risk among elderly patients with colon cancer. // Hem/Onc Today;12/10/2012, Vol. 13 Issue 23, p14
The article discusses a research which investigated the mortality risk of elderly patients with stage III colon cancer who developed venous thromboembolism after cancer diagnosis, published in a 2012 issue of the journal of "The Oncologist."
- Survival from cancer of the rectum in England and Wales up to 2001. Mitry, E.; Rachet, B.; Quinn, M. J.; Cooper, N.; Coleman, M. P. // British Journal of Cancer;9/2/2008 Supplement, Vol. 99, pS30
The article presents a survival analysis on rectal cancer England and Wales up to 2001. It notes on the trend of short-term predictions of survival for patients diagnosed during 2000-2001, using hybrid analysis which suggests no improvement in the future and the deprivation of gap in five-year...
- Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data. Capocaccia, R.; Gatta, G.; Dal Maso, L. // Annals of Oncology;Jun2015, Vol. 26 Issue 6, p1263
Background: Cancer survivorship is an increasingly important issue in cancer control. Life expectancy of patients diagnosed with breast, colon, and testicular cancers, stratified by age at diagnosis and time since diagnosis, is provided as an indicator to evaluate future mortality risks and...